Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radiko Holdings Corp GEATF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Radiko Holdings Corp through its subsidiaries, is engaged in cannabis product manufacturing and distributing. The group generates revenue from licensing fees, royalties and agreements with companies who distribute and sell products in the Cannabis Industry, as well from the direct sale of merchandise such as clothing, paraphernalia, posters, and other products. Its other brands include La Vida Verde, Blank Brand, and Skunk Feather.


GREY:GEATF - Post by User

Radiko Holdings Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(21)
•••
Post by Aceloveon Jan 31, 2019 12:20am
41 Views
Post# 29300027

Outstanding Shares

Outstanding Shares

Time to Curb Shareholder Dilution


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities